Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication

Table 2 Helicobacter pylori eradication rates

	MBST	Hybrid	P value
ITT analysis
Eradication rate	91.4% (128/140)	79.2% (114/144)	0.013
95%CI	90.2%-92.9%	77.3%-80.7%
PP analysis
Eradication rate	94.1% (128/136)	82.6% (114/138)	0.003
95%CI	92.9%-95.6%	80.6%-84.1%

ITT: Intention-to-treat; PP: Per-protocol; MBST: 14-d moxifloxacin-based sequential therapy; Hybrid: 14-d hybrid therapy.